MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 185 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2019. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $14,280 | +42.8% | 430 | +41.0% | 0.00% | – |
| Q3 2022 | $10,000 | +66.7% | 305 | +54.8% | 0.00% | – |
| Q2 2022 | $6,000 | -33.3% | 197 | -44.8% | 0.00% | – |
| Q1 2022 | $9,000 | +28.6% | 357 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | -56.2% | 357 | -56.0% | 0.00% | – |
| Q3 2021 | $16,000 | -11.1% | 811 | -0.7% | 0.00% | – |
| Q2 2021 | $18,000 | -33.3% | 817 | -21.5% | 0.00% | – |
| Q1 2021 | $27,000 | +575.0% | 1,041 | +571.6% | 0.00% | – |
| Q2 2020 | $4,000 | -97.7% | 155 | -99.1% | 0.00% | – |
| Q3 2019 | $171,000 | +8450.0% | 18,067 | +17612.7% | 0.00% | – |
| Q4 2018 | $2,000 | -75.0% | 102 | -79.1% | 0.00% | – |
| Q2 2018 | $8,000 | -99.7% | 489 | -99.6% | 0.00% | -100.0% |
| Q2 2013 | $2,829,000 | – | 131,580 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acuitas Investments, LLC | 283,983 | $6,299,000 | 3.15% |
| Euclidean Technologies Management, LLC | 128,088 | $2,841,000 | 2.26% |
| GLOBEFLEX CAPITAL L P | 185,939 | $4,124,000 | 0.74% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,194,000 | 0.66% |
| CLARK ESTATES INC/NY | 220,000 | $4,880,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,424,274 | $31,590,000 | 0.56% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 789,827 | $17,518,000 | 0.53% |
| EARNEST PARTNERS LLC | 3,885,748 | $86,186,000 | 0.51% |
| MOODY ALDRICH PARTNERS LLC | 137,075 | $3,040,000 | 0.43% |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | 414,323 | $9,190,000 | 0.33% |